[Polychemotherapy in patients with ovarian cancer]

The authors give a prospective randomized clinical estimation of the efficacy of two schedules of polychemotherapy in the complex treatment of 36 patients with far-advanced malignant ovarian tumors and their recurrences. An incomplete remission of various duration was gained in 4/5 of primary patients and in 3/5 of those with recurrences. The studies concerned failed to show any evident advantages of polychemotherapy over monochemotherapy.